Literature DB >> 2668084

Binding specificity and intramolecular signal transmission of uncleaved insulin proreceptor in transformed lymphocytes from a patient with extreme insulin resistance.

T Sasaoka1, Y Shigeta, Y Takata, M Sugibayashi, A Hisatomi, M Kobayashi.   

Abstract

An alteration of an amino acid sequence in the processing site of the insulin proreceptor by a point mutation of the insulin receptor gene produced extreme insulin resistance. We characterized functional properties of the unprocessed insulin receptor in transformed lymphocytes from a patient. Insulin binding to intact cells and to a partially purified insulin receptor preparation was radically decreased to 20% and 18% of the control values, respectively. In competitive insulin binding to intact cells, [LeuA3]-, [LeuB24]-, [SerB24]-insulin, and mini-proinsulin ([ B(1-29)-Ala-Ala-Lys-A(1-21)]-insulin) had the same relative binding activity in both the patient's and the control cells, but proinsulin and IGF-I were markedly less able to displace 125I-insulin in the patient's cells. In contrast to the study in intact cells, proinsulin and IGF-I as well as other insulin analogues had the same relative binding activity to bind to the partially lectin-purified insulin receptor preparations from both the patient's and the control cells. As regards the signal transduction after receptor binding, insulin-stimulated autophosphorylation of the unprocessed insulin proreceptor occurred proportionally to the amount of decreased insulin binding. With 0.025% trypsin treatment, the abnormal binding characteristics and autophosphorylation were normalized through conversion to functionally normal receptors. In spite of the abnormal processing, self-association of receptors into oligomeric structures was observed in the proreceptor. These results suggest that the unprocessed insulin proreceptor in the plasma membranes has an altered conformation which affects its binding characteristics but not its intramolecular signal transmission.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668084     DOI: 10.1007/bf00277261

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  41 in total

1.  Insulin resistance by uncleaved insulin proreceptor. Emergence of binding site by trypsin.

Authors:  M Kobayashi; T Sasaoka; Y Takata; A Hisatomi; Y Shigeta
Journal:  Diabetes       Date:  1988-05       Impact factor: 9.461

2.  Receptor binding and negative cooperativity of a mutant insulin, [LeuA3]-insulin.

Authors:  M Kobayashi; Y Takata; O Ishibashi; T Sasaoka; T M Iwasaki; Y Shigeta; K Inouye
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

3.  Extreme insulin resistance in association with abnormally high binding affinity of insulin receptors from a patient with leprechaunism: evidence for a defect intrinsic to the receptor.

Authors:  S I Taylor; J A Hedo; L H Underhill; M Kasuga; M J Elders; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

4.  A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor.

Authors:  H Riedel; T J Dull; J Schlessinger; A Ullrich
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

5.  A primary defect in insulin receptor in a young male patient with insulin resistance.

Authors:  Y Takata; M Kobayashi; H Maegawa; N Watanabe; O Ishibashi; Y Shigeta; A Fujinami
Journal:  Metabolism       Date:  1986-10       Impact factor: 8.694

6.  Unprocessed insulin proreceptor in cultured fibroblasts from a patient with extreme insulin resistance.

Authors:  T Sasaoka; Y Shigeta; Y Takata; O Ishibashi; M Sugibayashi; A Hisatomi; M Kobayashi
Journal:  Metabolism       Date:  1989-10       Impact factor: 8.694

7.  Primary defect of insulin receptors in skin fibroblasts cultured from an infant with leprechaunism and insulin resistance.

Authors:  E E Schilling; M M Rechler; C Grunfeld; A M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism.

Authors:  M Kobayashi; J M Olefsky; J Elders; M E Mako; B D Given; H K Schedwie; R H Fiser; R L Hintz; J A Horner; A H Rubenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity.

Authors:  M Kobayashi; S Ohgaku; M Iwasaki; H Maegawa; Y Shigeta; K Inouye
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

10.  Transmembrane signaling of interleukin 2 receptor. Conformation and function of human interleukin 2 receptor (p55)/insulin receptor chimeric molecules.

Authors:  M Hatakeyama; T Doi; T Kono; M Maruyama; S Minamoto; H Mori; M Kobayashi; T Uchiyama; T Taniguchi
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more
  5 in total

1.  The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2).

Authors:  Imène Kara; Marjorie Poggi; Bernadette Bonardo; Roland Govers; Jean-François Landrier; Sun Tian; Ingo Leibiger; Robert Day; John W M Creemers; Franck Peiretti
Journal:  J Biol Chem       Date:  2014-12-19       Impact factor: 5.157

2.  A mutation (Trp1193-->Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance.

Authors:  M Iwanishi; T Haruta; Y Takata; O Ishibashi; T Sasaoka; K Egawa; T Imamura; K Naitou; T Itazu; M Kobayashi
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

3.  Long-term follow up in type A insulin resistant syndrome treated by insulin-like growth factor I.

Authors:  H Ishihama; Y Suzuki; K Muramatsu; M Nagai; M Kokubo; H Shiraya; A Kawakita; Y Nishimura; T Imamura; M Kobayashi
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

4.  An extracellular domain of the beta subunit is essential for processing, transport and kinase activity of insulin receptor.

Authors:  T Haruta; T Sawa; Y Takata; T Imamura; Y Takada; H Morioka; G H Yang; M Kobayashi
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

5.  Functionally distinct insulin receptors generated by tissue-specific alternative splicing.

Authors:  L Mosthaf; K Grako; T J Dull; L Coussens; A Ullrich; D A McClain
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.